- ≥98% by HPLC; lot-matched COA available
- Lot-matched certificate of analysis
- Ships next business day, tracked
Noopept
N-phenylacetyl-L-prolylglycine ethyl ester, a dipeptide-derived nootropic compound
- FormOral capsules in a sealed bottle with desiccant
- Mol. weight318.37 g/mol
- Research areasNGF and BDNF mRNA expression, hippocampal memory paradigms, anxiolytic and neuroprotective animal models
Supplied for laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease.
Overview
Noopept is the common name for N-phenylacetyl-L-prolylglycine ethyl ester, a synthetic compound built on a proline–glycine dipeptide backbone with a phenylacetyl group at the N-terminus and an ethyl ester at the C-terminus. Its formula is C17H22N2O4 and its molecular weight 318.37 g/mol, making it far smaller than the peptide nootropics it is usually compared with, such as Semax and Selank. It was developed at the Zakusov Institute of Pharmacology in Moscow as a dipeptide analogue of the racetam scaffold.
Laboratory interest centres on reports of nerve growth factor and BDNF mRNA changes in rodent hippocampus, on anxiolytic and neuroprotective endpoints in animal models, and on comparisons with piracetam-family compounds. We supply Noopept as finished capsules in a sealed bottle at two research strengths, HPLC tested with a lot-matched Certificate of Analysis available. Laboratory research use only.
Specifications
Identity
- CAS number
- 157115-85-0
- Molecular formula
- C17H22N2O4
- Molecular weight
- 318.37 g/mol
Supply & purity
- Form
- Oral capsules in a sealed bottle with desiccant
- Purity
- ≥98% by HPLC; lot-matched COA available
- Available sizes
- 10 mg × 60 capsules, 30 mg × 60 capsules
Additional detail
- Chemical name
- Ethyl N-phenylacetyl-L-prolylglycinate
- Also known as
- Noopept, GVS-111, omberacetam
- Compound class
- Dipeptide-derived nootropic (proline-glycine backbone, N-phenylacetylated, C-terminal ethyl ester)
- Principal metabolite
- Cycloprolylglycine (cyclo-Pro-Gly), an endogenous cyclic dipeptide
- Research areas
- NGF and BDNF mRNA expression, hippocampal memory paradigms, anxiolytic and neuroprotective animal models
- Regulatory status
- Not approved in the United States; does not meet the statutory definition of a dietary ingredient
- Reconstitution
- None required — supplied in finished capsule form
- Storage
- Room temperature in the sealed bottle, protected from light, heat and humidity
Questions about Noopept
What is Noopept?
Noopept is N-phenylacetyl-L-prolylglycine ethyl ester, a synthetic compound built on a proline-glycine dipeptide backbone. Developed in Russia as a dipeptide analogue of the racetam scaffold, it is used in laboratory research on neurotrophin expression, memory paradigms and neuroprotection models.
Is Noopept a peptide?
Only in part. It contains a proline-glycine dipeptide core, but the N-terminal phenylacetyl group and C-terminal ethyl ester make it behave as a small molecule rather than a conventional peptide. At 318.37 g/mol it is much smaller than peptide nootropics such as Semax or Selank.
How is purity verified?
Every lot is tested by HPLC for purity of at least 98% and checked for identity against the expected 318.37 g/mol mass. The lot-matched Certificate of Analysis is available on this product page before purchase and documents the full analytical results.
What sizes are available?
Noopept is supplied as 10 mg × 60 capsules and 30 mg × 60 capsules in sealed bottles with desiccant. Two strengths in the same capsule count make concentration comparisons straightforward without weighing bulk powder in the laboratory.
Is Noopept legal to sell as a supplement?
No. In the United States it is not an approved drug and does not meet the statutory definition of a dietary ingredient, so it cannot lawfully be marketed as a dietary supplement. It is listed here strictly as a research chemical for laboratory use.
Related
